Journal Finder

The biological approach to mental disorders continues to yield innovative findings of clinical importance, particularly if methodologies are combined. This journal collects high-quality empirical studies from various experimental and clinical approaches in the fields of biological psychiatry, biological psychology, and neuropsychology. It features original, clinical, and basic research in the fields of neurophysiology and functional imaging, neuropharmacology and neurochemistry, neuroendocrinology and neuroimmunology, genetics, and their relationships with normal psychology and psychopathology. In addition, coverage includes studies on animal models of mental disorders and therapeutic interventions, and pharmacoelectroencephalographic studies, as well as reviews on new methodological approaches.

Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely behavioral studies and toxicology studies will not be published unless they have directly demonstrable relevance to the areas of pharmacology or biochemistry. Papers describing the behavioral effects of novel psychoactive drugs in models of psychiatric diseases must include a positive control.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Progress in Neuro-Psychopharmacology & Biological Psychiatry does not publish work on the actions of biological extracts unless the pharmacological active molecular substrate and/or specific receptor binding properties of the extract compounds are elucidated.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservices author services .

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/525488/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Psychiatric Genetics addresses new areas of research which have been opened up following the success of new technology in cloning many genes related to brain structure and function. The journal publishes groundbreaking papers that bring together clinical observations, psychological abnormalities and genetic marker data. Areas such as twin studies, adoption studies, genetic/biological markers and family/pedigree studies also fall within the scope. Website: www.psychgenetics.com.

The journal provides very rapid publication of short but complete research reports in the field of psychiatry. The scope of the journal encompasses: (1) Biochemical, physiological, genetic, psychological, and social determinants of human behavior;(2) Assessment of human behavior and subjective state;(3) Evaluation of somatic and non-somatic psychiatric treatments.In addition, reports of clinically related basic studies in the fields of neuropharmacology, neurochemistry, neuroendocrinology, electrophysiology, psychology, genetics, and brain imaging are published. Significant methodological advances such as instrumentation, clinical scales, and assays directly applicable to psychiatric research are also appropriate.Brief reviews, theoretical contributions, and letters to the editor will be considered.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Psychoneuroendocrinology publishes papers dealing with the interrelated disciplines of psychology, neurobiology, endocrinology, immunology, neurology, and psychiatry, with an emphasis on multidisciplinary studies aiming at integrating these disciplines in terms of either basic research or clinical implications. One of the main goals is to understand how a variety of psychobiological factors interact in the expression of the stress response as it relates to the development and/or maintenance of neuropsychiatric illnesses. The journal is international and comprises original research papers, reviews of an area of the literature, or at an appropriate stage in the development of the author's own work, commentaries in areas of current interest, short communications and book reviews. Although reviews, editorials and commentaries are usually by invitation, interested authors can contact one of the Co-Editors-in-Chief to discuss the suitability of topics for either category of manuscripts.Electronic usage:An increasing number of readers access the journal online via ScienceDirect, one of the world's most advanced web delivery systems for scientific, technical and medical information.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

As official journal of the Schizophrenia International Research Society (SIRS)Schizophrenia Research is THE journal of choice for international researchers and clinicians to share their work with the global schizophrenia research community. More than 6000 institutes have online or print (or both) access to this journal - the largest specialist journal in the field, with the largest readership!Schizophrenia Research's time to first decision is as fast as 6 weeks and its publishing speed is as fast as 4 weeks until online publication (corrected proof/Article in Press) after acceptance and 14 weeks from acceptance until publication in a printed issue.The journal publishes novel papers that really contribute to understanding the biology and treatment of schizophrenic disorders; Schizophrenia Research brings together biological, clinical and psychological research in order to stimulate the synthesis of findings from all disciplines involved in improving patient outcomes in schizophrenia.

The Lancet Psychiatry launched in print and online in June 2014, following in the footsteps of other Lancet specialty journals such as The Lancet Oncology and The Lancet Neurology. The journal offers the same fast track experience offered by its sister journals for all authors of research papers that are selected for peer review, where articles can be published online within 8 weeks of submission.

The journal publishes a range of article types in psychiatry, including Original Research, Reviews, Personal Views, Comments, and News articles. Topics include psychopharmacology, psychotherapy and psychosocial approaches to all psychiatric disorders, across the life course. The journal covers innovative treatments and the biological research underpinning such developments, novel methods of service delivery, and new ways of thinking about mental illness promoted by social psychiatry. The journal will also advocate strongly for the rights of people with mental health disorders, and welcome the voices of service users.

Visit http://www.thelancet.com/psychiatrywww.thelancet.com/psychiatry for more information.

Translational Psychiatry is a sister journal to the well-established and number-one journal in psychiatry, Molecular Psychiatry*, but explores the more translational area between the research in neuroscience and conceptually novel treatments. The editorial team is led by Julio Licinio, MD, and includes a highly respected international editorial board. Together, the Translational Psychiatry editorial team and NPG look to further define and shape the field of psychiatry and neuroscience.